[TABLE OF CONTENTS]

1 INTRODUCTION OF GLOBAL MICROALGAE-BASED PRODUCTS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY: MICROALGAE-BASED PRODUCTS MARKET

3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS

4 GLOBAL MICROALGAE-BASED PRODUCTS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE

5 GLOBAL MICROALGAE-BASED PRODUCTS MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 ASTAXANTHIN
5.3 B-CAROTENE
5.4 SPIRULINA
5.5 CHLORELLA
5.6 PUFA
5.7 LUTEIN
5.8 OTHERS

6 GLOBAL MICROALGAE-BASED PRODUCTS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 FOOD & BEVERAGES
6.3 DIETARY SUPPLEMENT & PHARMACEUTICAL
6.4 PERSONAL CARE
6.5 ANIMAL FEED & AQUACULTURE
6.6 BIOCHAR/FERTILIZER
6.7 OTHERS

7 GLOBAL MICROALGAE-BASED PRODUCTS MARKET, BY GEOGRAPHY
7.1 OVERVIEW

7.2 NORTH AMERICA

7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO

7.3 EUROPE

7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE

7.4 ASIA PACIFIC

7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC

7.5 MIDDLE EAST & AFRICA

7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA

7.6 SOUTH AMERICA

7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA

8 GLOBAL MICROALGAE-BASED PRODUCTS MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
8.4 COMPETITIVE DASHBOARD
8.5 PRODUCT MAPPING
8.6 TOP PLAYER POSITIONING, 2022
8.7 COMPETITIVE HEATMAP
8.8 TOP WINNING STRATEGIES

9 COMPANY PROFILES

9.1 PHYCOM
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.2 DSM N.V.
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.3 CHR. HANSEN HOLDING A/S
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.4 VEDAN BIOTECHNOLOGY CORP
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.5 DIC CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.6 NATUREX S.A
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.7 ALLMICROALGAE NATURAL PRODUCTS S.A
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.8 FUQING KING DNARMSA SPIRULINA CO. LTD
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.9 BEIJING GINGKO GROUP
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.10 DIVI’S LABORATORIES LTD
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS
9.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.11 NOW HEALTH GROUP, INC
9.11.1 OVERVIEW
9.11.2 FINANCIAL PERFORMANCE
9.11.3 PRODUCT OUTLOOK
9.11.4 KEY DEVELOPMENTS
9.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.12 MONZÓN BIOTECH
9.12.1 OVERVIEW
9.12.2 FINANCIAL PERFORMANCE
9.12.3 PRODUCT OUTLOOK
9.12.4 KEY DEVELOPMENTS
9.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.13 CYANOTECH CORPORATION
9.13.1 OVERVIEW
9.13.2 FINANCIAL PERFORMANCE
9.13.3 PRODUCT OUTLOOK
9.13.4 KEY DEVELOPMENTS
9.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.14 ALGATECHNOLOGIES LTD
9.14.1 OVERVIEW
9.14.2 FINANCIAL PERFORMANCE
9.14.3 PRODUCT OUTLOOK
9.14.4 KEY DEVELOPMENTS
9.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.15 REED MARICULTURE
9.15.1 OVERVIEW
9.15.2 FINANCIAL PERFORMANCE
9.15.3 PRODUCT OUTLOOK
9.15.4 KEY DEVELOPMENTS
9.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.16 ARIZONA ALGAE PRODUCTS LLC
9.16.1 OVERVIEW
9.16.2 FINANCIAL PERFORMANCE
9.16.3 PRODUCT OUTLOOK
9.16.4 KEY DEVELOPMENTS
9.16.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.17 SUN CHLORELLA CORPORATION
9.17.1 OVERVIEW
9.17.2 FINANCIAL PERFORMANCE
9.17.3 PRODUCT OUTLOOK
9.17.4 KEY DEVELOPMENTS
9.17.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.18 YAEYAMA SHOKUSAN CO LTD.
9.18.1 OVERVIEW
9.18.2 FINANCIAL PERFORMANCE
9.18.3 PRODUCT OUTLOOK
9.18.4 KEY DEVELOPMENTS
9.18.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.19 TAIWAN CHLORELLA MANUFACTURING CO. LTD
9.19.1 OVERVIEW
9.19.2 FINANCIAL PERFORMANCE
9.19.3 PRODUCT OUTLOOK
9.19.4 KEY DEVELOPMENTS
9.19.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

9.20 FAR EAST MICROALGAE IND CO. LTD
9.20.1 OVERVIEW
9.20.2 FINANCIAL PERFORMANCE
9.20.3 PRODUCT OUTLOOK
9.20.4 KEY DEVELOPMENTS
9.20.5 KEY STRATEGIC MOVES AND DEVELOPMENTS